GLYCABEN

GLYCABEN is an FDA 510(k)-cleared medical device (K893453) manufactured by Exocell, Inc.. This device is classified under the Hematology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on October 22, 1989. Regulation: 8.